Haleon (LON:HLN) Posts Earnings Results

Key Points

• Haleon reported earnings of GBX 8.90 ($0.12) per share for the quarter, with a return on equity of 6.54% and a net margin of 9.66%.
• Shares of Haleon traded at GBX 365.83 ($4.83) after an increase of GBX 6.33 ($0.08), with a market cap of £33.02 billion and a price-to-earnings ratio of 30.77.
• JPMorgan Chase & Co. reaffirmed an "underweight" rating on Haleon, while the Royal Bank Of Canada set a target price of GBX 370 ($4.89) for the shares.

Haleon (LON:HLN - Get Free Report) posted its earnings results on Thursday. The company reported GBX 8.90 ($0.12) EPS for the quarter, Digital Look Earnings reports. Haleon had a return on equity of 6.54% and a net margin of 9.66%.

Haleon Stock Performance

Shares of Haleon stock traded up GBX 6.33 ($0.08) on Friday, hitting GBX 365.83 ($4.83). The stock had a trading volume of 24,234,371 shares, compared to its average volume of 25,435,422. The stock has a market cap of £33.02 billion, a price-to-earnings ratio of 30.77, a price-to-earnings-growth ratio of 1.49 and a beta of 0.19. Haleon has a twelve month low of GBX 346.10 ($4.57) and a twelve month high of GBX 419.50 ($5.54). The company has a quick ratio of 0.93, a current ratio of 0.84 and a debt-to-equity ratio of 53.36. The business's 50 day moving average is GBX 382.62 and its two-hundred day moving average is GBX 385.08.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on HLN shares. JPMorgan Chase & Co. reaffirmed an "underweight" rating on shares of Haleon in a research report on Friday. Royal Bank Of Canada reaffirmed a "sector perform" rating and issued a GBX 370 ($4.89) target price on shares of Haleon in a research report on Thursday.

Insider Buying and Selling

In related news, insider Blathnaid Bergin purchased 6,145 shares of Haleon stock in a transaction that occurred on Friday, May 16th. The shares were acquired at an average price of GBX 404 ($5.34) per share, with a total value of £24,825.80 ($32,794.98). Also, insider Dawn Allen sold 64,329 shares of the stock in a transaction that occurred on Monday, June 30th. The stock was sold at an average price of GBX 376 ($4.97), for a total value of £241,877.04 ($319,520.53). 10.74% of the stock is currently owned by company insiders.

About Haleon

Haleon LSE / NYSE: HLN is a world-leading consumer health company, with a clear purpose to deliver better everyday health with humanity. In July 2022, it listed as an independent company on the London and New York Stock Exchanges. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.